サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1756492

症候群マルチプレックス診断市場：タイプ別、最終用途別、国別、地域別- 産業分析、市場規模、市場シェア、2024～2032年予測

Syndromic Multiplex Diagnostics Market, By Type, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 357 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
症候群マルチプレックス診断市場：タイプ別、最終用途別、国別、地域別- 産業分析、市場規模、市場シェア、2024～2032年予測
出版日: 2025年05月23日
発行: AnalystView Market Insights
ページ情報: 英文 357 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

症候群マルチプレックス診断市場規模は2024年に28億8,976万米ドルとなり、2024～2032年にかけてCAGR 4.2％で拡大

症候群マルチプレックス診断市場-市場力学

迅速かつ正確な診断に対する需要の高まり

迅速かつ正確な疾患の特定に対するニーズの高まりは、症候群マルチプレックス診断市場の主要な促進要因です。従来型診断法は時間がかかることが多く、一度に1つの病原体を検出するのが限界でした。対照的に、症候群パネルは、迅速な納期と、単一のサンプルから複数の病原体を同時に検出する能力を記載しています。このことは、タイムリーな診断が患者の転帰に大きな影響を与える感染症のアウトブレイクやクリティカルケアの現場での管理に特に有用です。公衆衛生への備えと抗菌薬スチュワードシップに対する世界の関心の高まりは、このような先進的診断薬への需要をさらに高めています。

症候群マルチプレックス診断市場-主要な洞察

当社のリサーチアナリストによると、症候群マルチプレックス診断の世界市場は、2024～2032年の間に約4.2%のCAGRで開発される見込みです。

2024年のタイプ別セグメントでは、呼吸器カテゴリーが市場を独占しています。

最終用途別では、2024年に最も収益を上げたのは病院セグメントでした。

地域別では、2024年に北米が最も収益を上げた地域でした。

症候群マルチプレックス診断市場-セグメンテーション分析

世界の症候群マルチプレックス診断市場は3つのカテゴリーに分類されます：タイプ、エンドユーザー、地域です。

症候群マルチプレックス診断市場は、タイプ別に呼吸器、消化器、中枢神経系（CNS）、その他のタイプに区分され、これには複雑性尿路感染症（cUTI）や性感染症（STD）が含まれます。このうち、呼吸器領域が市場で圧倒的なシェアを占めています。この優位性は、特に季節性インフルエンザの流行時やCOVID-19のようなパンデミック時に、呼吸器感染症の有病率が高いことが主要因です。1つのサンプルから複数の呼吸器病原体を迅速に同定する必要性は、臨床効率を高め、効果的な感染対策をサポートします。さらに、早期診断に対する意識の高まりと、病院やポイントオブケア環境における症候群パネルの採用増加により、呼吸器マルチプレックス診断ソリューションの需要は引き続き高まっています。

最終用途別では、症候群マルチプレックス診断市場は、病院、診断ラボ、その他（クリニック、研究機関、ポイントオブケアを含む）に区分されます。このうち、病院は患者数が多く、緊急の治療が必要であり、先進的診断技術へのアクセスが容易であることから、圧倒的なシェアを占めています。病院では、迅速かつ包括的な検査を必要とする複雑な症例に対応することが多く、症候群パネルはこれを効率的に記載しています。救急部や集中治療室でのマルチプレックス診断の統合は、特に感染症の流行時に、タイムリーな意思決定とより良い患者管理を可能にします。その他の特典として、病院は院内の検査室と訓練された人員から恩恵を受けることができ、重要な症候群検査用途にこれらの技術が広く採用されることをさらに後押しします。

症候群マルチプレックス診断市場-地理的洞察

症候群マルチプレックス診断市場は、北米、アジア太平洋、ラテンアメリカ、欧州、中東・アフリカの各地域に分布しています。これらの地域は、ビジネスをもたらしている国に基づいてさらに分割されます。

北米は症候群マルチプレックス診断市場において支配的な地位を占めているが、その主要理由は先進的ヘルスケアインフラ、強力な研究開発能力、革新的な診断技術の早期導入です。特に米国は、分子診断薬への多額の投資と、疾病の早期発見を向上させることを目的とした公衆衛生への取り組みにより、この地域をリードしています。感染症に対する認識の広まり、政府からの資金援助、確立された償還の枠組みが市場の成長をさらに後押ししています。さらに、呼吸器感染症や慢性疾患の有病率の高さ、病院や診断ラボの強固なネットワークが、北米が世界の症候群マルチプレックス診断において主導的な役割を果たしていることを裏付けています。

欧州は、効率的な診断ソリューションに対する需要の高まりと、先進医療技術に対する規制当局の強力な支援により、症候群マルチプレックス診断市場のもう一つの主要地域です。ドイツ、英国、フランスなどの国々が最先端を走っており、近代的なヘルスケアシステムと大規模な公衆衛生投資の恩恵を受けています。同地域では、抗菌薬スチュワードシップと感染制御に重点を置いているため、臨床現場でのマルチプレックスパネルの採用が加速しています。さらに、高齢者の増加と呼吸器感染症と消化器感染症の罹患率の上昇が、需要をさらに押し上げています。欧州はヘルスケアの革新に取り組んでおり、同市場における主要な参入企業です。

症候群マルチプレックス診断市場-競合情勢

症候群マルチプレックス診断市場は、大手診断薬メーカーと革新的な新規参入企業によって形成されています。Abbott Laboratories、Thermo Fisher Scientific、F. Hoffmann-La Roche、Qiagen、bioMerieuxなどの大手企業は、包括的なマルチプレックスパネルと先進的な分子プラットフォームで優位を占めています。これらの企業は、検査精度の向上、所要時間の短縮、病原体カバー範囲の拡大のため、研究開発に多額の投資を行っています。新規参入企業は、ニッチ市場を獲得するため、迅速なポイントオブケアソリューションの開発に注力しています。戦略的提携、合併、買収により、市場での地位はさらに強化されます。このような競合環境は、絶え間ない技術革新を促し、診断能力を向上させ、タイムリーで効果的な患者ケアを世界中で支えています。

目次

第1章 症候群マルチプレックス診断市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 症候群マルチプレックス診断の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 症候群マルチプレックス診断産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長展望マッピング
  • 規制枠組み分析

第5章 症候群マルチプレックス診断市場： COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 症候群マルチプレックス診断市場情勢

  • 症候群マルチプレックス診断市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • ベテラン選手の分析
    • 新興企業の分析

第7章 症候群マルチプレックス診断市場-タイプ別

  • 概要
    • タイプ別セグメントシェア分析
    • 呼吸器
    • 消化器
    • 中枢神経系（CNS）
    • その他の症候群（cUTIとSTD）

第8章 症候群マルチプレックス診断市場-最終用途別

  • 概要
    • 最終用途別セグメントシェア分析
    • 病院
    • 診断ラボ
    • その他

第9章 症候群マルチプレックス診断市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 韓国
    • 日本
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析-症候群マルチプレックス診断産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Abbott Laboratories
    • Thermo Fisher Scientific, Inc.
    • F. Hoffmann-La Roche Ltd
    • Qiagen
    • bioMerieux
    • DiaSorin SpA（Luminex Corporation）
    • Hologic, Inc.
    • Becton, Dickinson and Company（BD）
    • Applied BioCode
    • QIAGEN
    • Curetis GmbH
    • その他

第11章 アナリストの全方位展望

目次
Product Code: ANV5248

REPORT HIGHLIGHT

Syndromic Multiplex Diagnostics Market size was valued at USD 2,889.76 Million in 2024, expanding at a CAGR of 4.2% from 2024 to 2032.

Syndromic multiplex diagnostics is an advanced diagnostic approach that simultaneously tests for multiple pathogens or biomarkers associated with a specific syndrome using a single test panel. This method integrates molecular techniques, such as PCR, to rapidly identify the causative agents of illnesses with overlapping symptoms like respiratory, gastrointestinal, or neurological infections. By targeting a broad spectrum of pathogens in one test, it enhances diagnostic accuracy, reduces time to treatment, and supports more effective clinical decision-making. This approach is particularly useful in settings where rapid identification of the illness source is critical, such as hospitals, emergency care, and outbreak scenarios.

Syndromic Multiplex Diagnostics Market- Market Dynamics

Rising Demand for Rapid and Accurate Diagnostics

The growing need for fast and precise disease identification is a key driver for the syndromic multiplex diagnostics market. Traditional diagnostic methods are often time-consuming and limited to detecting one pathogen at a time. In contrast, syndromic panels offer quicker turnaround times and the ability to detect multiple pathogens simultaneously from a single sample. This is especially valuable in managing infectious disease outbreaks and in critical care settings, where timely diagnosis can significantly impact patient outcomes. Increased global focus on public health preparedness and antimicrobial stewardship further fuels the demand for such advanced diagnostics.

Syndromic Multiplex Diagnostics Market- Key Insights

According to our research analyst, the global Syndromic Multiplex Diagnostics Market is expected to develop at a CAGR of approximately 4.2% between 2024-2032.

Segmented by Type in 2024, the Respiratory category dominated the market.

Based on End Use, the Hospitals segment generated the most income in 2024.

On the basis of region, in 2024, North America was the region with the highest revenue.

Syndromic Multiplex Diagnostics Market- Segmentation Analysis:

The global Syndromic Multiplex Diagnostics Market is divided into Three categories: Type, End-user, and Region.

The syndromic multiplex diagnostics market is segmented by type into Respiratory, Gastrointestinal, Central Nervous System (CNS), and Other Types of Syndromes, which include complicated urinary tract infections (cUTIs) and sexually transmitted diseases (STDs). Among these, the Respiratory segment holds the dominant share of the market. This dominance is primarily driven by the high prevalence of respiratory infections, especially during seasonal flu outbreaks and pandemics such as COVID-19. The need for rapid identification of multiple respiratory pathogens from a single sample enhances clinical efficiency and supports effective infection control measures. Moreover, growing awareness of early diagnosis and increasing adoption of syndromic panels in hospitals and point-of-care settings continue to bolster the demand for respiratory multiplex diagnostic solutions.

By end use, the syndromic multiplex diagnostics market is segmented into Hospitals, Diagnostic Laboratories, and Others, which include clinics, research institutes, and point-of-care settings. Among these, Hospitals represent the dominant segment due to their high patient volume, urgent care requirements, and greater access to advanced diagnostic technologies. Hospitals often deal with complex cases requiring rapid and comprehensive testing, which syndromic panels efficiently provide. The integration of multiplex diagnostics in emergency departments and intensive care units enables timely decision-making and better patient management, especially during infectious disease outbreaks. Additionally, hospitals benefit from in-house laboratories and trained personnel, further supporting the widespread adoption of these technologies for critical syndromic testing applications.

Syndromic Multiplex Diagnostics Market- Geographical Insights

Geographically, the Syndromic Multiplex Diagnostics Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America holds a dominant position in the syndromic multiplex diagnostics market, primarily due to its advanced healthcare infrastructure, strong R&D capabilities, and early adoption of innovative diagnostic technologies. The United States, in particular, leads the region with significant investments in molecular diagnostics and public health initiatives aimed at improving early disease detection. Widespread awareness of infectious diseases, government funding, and well-established reimbursement frameworks further support market growth. Additionally, the high prevalence of respiratory infections and chronic conditions, along with a robust network of hospitals and diagnostic laboratories, reinforces North America's leading role in the global syndromic multiplex diagnostics landscape.

Europe is another leading region in the syndromic multiplex diagnostics market, driven by increasing demand for efficient diagnostic solutions and strong regulatory support for advanced medical technologies. Countries such as Germany, the United Kingdom, and France are at the forefront, benefiting from modern healthcare systems and substantial public health investments. The region's focus on antimicrobial stewardship and infection control has accelerated the adoption of multiplex panels in clinical settings. Moreover, the growing elderly population and rising incidence of respiratory and gastrointestinal infections have further contributed to demand. Europe's commitment to healthcare innovation positions it as a key player in this market.

Syndromic Multiplex Diagnostics Market- Competitive Landscape:

The syndromic multiplex diagnostics market is shaped by established diagnostics giants and innovative newcomers. Leading players such as Abbott Laboratories, Thermo Fisher Scientific, F. Hoffmann-La Roche, Qiagen, and bioMerieux dominate with comprehensive multiplex panels and advanced molecular platforms. These companies invest heavily in R&D to enhance test accuracy, reduce turnaround times, and expand pathogen coverage. New entrants focus on developing rapid, point-of-care solutions to capture niche markets. Strategic collaborations, mergers, and acquisitions further strengthen market positions. This competitive environment drives continuous innovation, improving diagnostic capabilities and supporting timely, effective patient care worldwide.

Recent Developments:

In March 2025, Abbott launched a new rapid multiplex respiratory panel that delivers results in under 30 minutes, enhancing early diagnosis and treatment in clinical settings.

In January 2024, Thermo Fisher expanded its syndromic testing portfolio by acquiring a molecular diagnostics company specializing in automated PCR technologies, boosting its market reach.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd
  • Qiagen
  • Biomerieux
  • Diasorin S.P.A (Luminex Corporation)
  • Hologic, Inc.
  • Becton, Dickinson And Company (Bd)
  • Applied Biocode
  • Qiagen
  • Curetis Gmbh
  • Others

GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTICS MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032

  • Respiratory
  • Gastrointestinal
  • Central Nervous System
  • Other Types Of Syndromes (Cuti And Stds)

GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTICS MARKET, BY END-USE - MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Others

GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Syndromic Multiplex Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Syndromic Multiplex Diagnostics Market Snippet by Type
    • 2.1.2. Syndromic Multiplex Diagnostics Market Snippet by End Use
    • 2.1.3. Syndromic Multiplex Diagnostics Market Snippet by Country
    • 2.1.4. Syndromic Multiplex Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Syndromic Multiplex Diagnostics Key Market Trends

  • 3.1. Syndromic Multiplex Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Syndromic Multiplex Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Syndromic Multiplex Diagnostics Market Opportunities
  • 3.4. Syndromic Multiplex Diagnostics Market Future Trends

4. Syndromic Multiplex Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Syndromic Multiplex Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Syndromic Multiplex Diagnostics Market Landscape

  • 6.1. Syndromic Multiplex Diagnostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Syndromic Multiplex Diagnostics Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Respiratory
    • 7.1.3. Gastrointestinal
    • 7.1.4. Central Nervous System
    • 7.1.5. Other Types of Syndromes (cUTI and STDs)

8. Syndromic Multiplex Diagnostics Market - By End Use

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By End Use, 2023 & 2032 (%)
    • 8.1.2. Hospitals
    • 8.1.3. Diagnostic Laboratories
    • 8.1.4. Others

9. Syndromic Multiplex Diagnostics Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Syndromic Multiplex Diagnostics Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Syndromic Multiplex Diagnostics Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.7. France
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.8. Italy
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.9. Spain
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.10. United Kingdom
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.10.4. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.11. Russia
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.12. Netherlands
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.13. Sweden
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.14. Poland
      • 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.14.3. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.15. Rest of Europe
      • 9.3.15.1. Overview
      • 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.15.4. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Syndromic Multiplex Diagnostics Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.8. South Korea
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Syndromic Multiplex Diagnostics Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Syndromic Multiplex Diagnostics Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Syndromic Multiplex Diagnostics Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Abbott Laboratories
    • 10.2.2. Thermo Fisher Scientific, Inc.
    • 10.2.3. F. Hoffmann-La Roche Ltd
    • 10.2.4. Qiagen
    • 10.2.5. bioMerieux
    • 10.2.6. DiaSorin S.p.A (Luminex Corporation)
    • 10.2.7. Hologic, Inc.
    • 10.2.8. Becton, Dickinson and Company (BD)
    • 10.2.9. Applied BioCode
    • 10.2.10. QIAGEN
    • 10.2.11. Curetis GmbH
    • 10.2.12. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us